
News
Filter Results
Displaying 101–110 of 508
-
Apr 21, 2023
Clinical trial participants with advanced vision loss from RP were able to identify fruits and vegetables
-
Apr 19, 2023
Geographic Atrophy: The Advanced Form of Dry AMD
Geographic atrophy causes significant central vision loss and remains an unmet medical need.
-
Mar 30, 2023
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
Mar 2, 2023
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Feb 28, 2023
RD Fund Appoints Mark S. Blumenkranz, MD, MMS to Board of Directors
Ophthalmology visionary Mark S. Blumenkranz, MD, MMS, to join RD Fund’s Board.
-
Feb 21, 2023
Foundation Fighting Blindness to Host their Spring VisionWalks
These VisionWalk events taking place this spring will raise awareness and fund research finding treatments and cures for blinding retinal diseases.
-
Feb 18, 2023
Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the United States and 5 million worldwide.
This is the first time that a treatment has been approved for this leading cause of blindness.
-
Feb 13, 2023
The Foundation Makes an Impact on Retinal Research
The Foundation Fighting Blindness’ long-term impact on moving the inherited retinal disease field forward towards treatments and cures.
-
Jan 25, 2023
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
Session to have special translational research emphasis on PRPH2 and inherited macular dystrophies.
-
Jan 6, 2023
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
The investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.